Brodalumab in the Treatment of Various Forms of Psoriasis: A Narrative Review
Background: Brodalumab is a fully human monoclonal antibody that selectively targets the interleukin-17 receptor A (IL-17RA), blocking the activity of pro-inflammatory IL-17 cytokines. Purpose: The purpose of this study was to describe the efficacy and safety of brodalumab in treating various forms...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Ráidu: | Journal of Dermatology and Dermatologic Surgery |
| Fáttát: | |
| Liŋkkat: | https://journals.lww.com/10.4103/jdds.jdds_41_24 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|